Literature DB >> 35151003

Sympathetic nervous system and hypertension: New evidences.

Gino Seravalle1, Guido Grassi2.   

Abstract

Evidences collected in the past few years have strengthened the concept that the sympathetic nervous system plays a primary role in the development and progression of the hypertensive state, starting from the early stage, and in the hypertension-related cardiovascular diseases. Several pathophysiological mechanisms are involved. Among them the genetic background, the immune system in conjunction with sympathetic activation. The present review will briefly discuss the importance of the above mentioned mechanisms in the development of hypertension. The paper will also examine the sympathetic mechanisms underlying attended vs unattended blood pressure measurements as well as their role in resistant vs pseudo-resistant hypertension. Finally evidence from recent meta-analysis on the relevance of sympathetic nerve traffic activation in the pathogenesis of hypertension will be briefly discussed.
Copyright © 2022. Published by Elsevier B.V.

Entities:  

Keywords:  Arterial hypertension; Biomarkers; Genes; Heart rate; Microneurography; Sympathetic nervous system; Unattended blood pressure

Year:  2022        PMID: 35151003     DOI: 10.1016/j.autneu.2022.102954

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  2 in total

1.  Integrative physiological study of adaptations induced by aerobic physical training in hypertensive hearts.

Authors:  Suenimeire Vieira; Bruno A Aguilar; Ana Catarine Veiga; Stella V Philbois; Ana Caroline S Freitas; Karine P Rodrigues; Jens Tank; Hugo C D Souza
Journal:  Front Physiol       Date:  2022-08-19       Impact factor: 4.755

Review 2.  The role of renal nerve stimulation in percutaneous renal denervation for hypertension: A mini-review.

Authors:  Hui-Chun Huang; Hao-Min Cheng; Yook-Chin Chia; Yan Li; Huynh Van Minh; Saulat Siddique; Apichard Sukonthasarn; Jam Chin Tay; Yuda Turana; Narsingh Verma; Kazuomi Kario; Tzung-Dau Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-09       Impact factor: 2.885

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.